Trimble Spitzer

Trimble Spitzer

Auto-generated profile, based on publicly available information

Trimble Spitzer

Uniformed Services University of the Health Sciences , Bethesda, MD 20814

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 August 2024 in Fertility and Sterility
Verified
Journal Article
Closed access
DBDavid Boedeker
David Boedeker
MBMarja Brolinson
Marja Brolinson
ACAlexandra C. Campedelli
Alexandra C. Campedelli
RYRona Yu
Rona Yu
SRSorana Raiciulescu
Sorana Raiciulescu
TSTrimble Spitzer
Trimble Spitzer

18 April 2023 in Journal of Endometriosis and Pelvic Pain Disorders
Verified
Journal Article
Closed access
ASAshley Murphy Shaw
Ashley Murphy Shaw
KDKara Demarco
Kara Demarco
LBLaura Belovs
Laura Belovs
RSRobert Strange
Robert Strange
TSTrimble Spitzer
Trimble Spitzer
Introduction: While the diagnosis of endometriosis is relatively common, thoracic endometriosis is a rare manifestation. Thoracic Endometriosis Syndrome (TES) most commonly presents with pneumothorax, 3% which are bilateral, making this case unique in the already limited breadth of TES with catamenial hemopneumothorax. Additionally, this patient had laboratory values constant with ovarian suppression yet continued menses and recurrent hemopneumothorax, necessitating surgical intervention. We propose that with this severity of disease a combination of surgical intervention and hormonal therapy is the ideal approach, providing the lowest rate of recurrence. Case description: A 33 year old woman with 2-day history of chest pain and shortness of breath with heavy menstrual cycles and significant dysmenorrhea. A chest radiograph and computed tomography scan revealed right-sided pneumothorax and bilateral hemothoraces with left-sided diaphragmatic hernia. Video-assisted thoracoscopic surgery confirmed sanguinous pleural effusions and biopsy proven endometriotic lesions. The patient was started on a gonadotropin-releasing hormone agonist and experienced short-interval recurrence of her symptoms. An aromatase inhibitor was added to her regimen and she underwent a left diaphragmatic hernia repair. Conclusions: The recurrence of symptoms despite complete hypothalamic-pituitary-ovarian axis suppression, in addition to the surgical requirements and findings make this case unique in the already limited breadth of thoracic endometriosis syndrome with catamenial hemopneumothorax.

16 April 2026 in Military Medicine
Verified
Journal Article
Closed access
KHKiley Hunkler
Kiley Hunkler
DBDavid Boedeker
David Boedeker
ELElisabeth Lee
Elisabeth Lee
EVEmily Viera
Emily Viera
ADAshley Diekemper
Ashley Diekemper
TSTrimble Spitzer
Trimble Spitzer
Introduction: Oocyte cryopreservation is an essential option for individuals to preserve their fertility. Although many patients perceive planned oocyte cryopreservation as a guarantee for delayed childbearing, a high success rate of achieving a subsequent pregnancy is strongly tied to the number of mature oocytes cryopreserved. There are numerous well-documented barriers to pursuing fertility preservation and achieving these age-recommended oocyte minimums. However, few studies have specifically analyzed the military healthcare system, which offers uniquely subsidized fertility care. The objective of this study was to evaluate military service members’ understanding of age-related oocyte cryopreservation recommendations and identify challenges in achieving these targets within the military healthcare system. Materials and Methods: This study was reviewed by our institution’s IRB and determined it was not human research. This mixed-methods study employed both quantitative surveys and qualitative interviews to assess knowledge of age-dependent fertility preservation guidelines and explore personal, systemic, and logistical barriers that may impact service members’ ability to meet their recommended oocyte count. Eligible participants included all patients presenting for planned oocyte cryopreservation at our institution from March 2023 to August 2024. We excluded all patients presenting for planned embryo cryopreservation, patients who underwent unplanned oocyte cryopreservation because of inability to extract sperm, and patients presenting for planned oocyte cryopreservation in anticipation of gonadotoxic treatment. Results: Of 54 eligible participants, 22 responded (response rate 40.7%), and 7 individuals participated in follow-up interviews. The majority of survey respondents were cisgender women (95.5%), who expressed plans to have 2 children in the future (63.6%). The primary motivations for choosing oocyte cryopreservation were the desire for a “sense of insurance” (59.1%) and the ability “to genetically build [their] families” (45.5%). Regarding oocyte retrieval outcomes, 68.2% of participants obtained 10 or fewer oocytes during their first cycle, with most participants stating that this number was lower than they had anticipated (59.1%). Only 36.4% successfully cryopreserved enough oocytes to reach an 80% chance of a live birth in the future. Almost half of our participants (45.5%) expressed interest but ultimately deferred another cycle, with many endorsing cost (35.0%) and the physical or emotional strain of the process (20.0%) as barriers to additional cycles. Our qualitative analysis of the follow-up interviews identified 5 major themes: risk mitigation, non-chargeable leave policy, financial burden, conflicting emotions, and military culture. Conclusions: This study underscores significant strides in increasing access to care for military service members, yet highlights additional cost barriers that influence participants’ ability to achieve age-related recommended oocyte minimums.

26 November 2025 in Military Medicine
Verified
Journal Article
Closed access
KHKiley F Hunkler
Kiley F Hunkler
DBDavid Boedeker
David Boedeker
ELElisabeth Lee
Elisabeth Lee
MZMichael Zamani
Michael Zamani
BMBright Mills
Bright Mills
TSTrimble Spitzer
Trimble Spitzer
Introduction: Demand for reproductive endocrinology and infertility (REI) specialists has increased with rising utilization of assisted reproductive technology. As a reflection of societal trends, the military medical system has noted increased call for infertility services and specialty-trained expertise. Recent Department of Defense Amendments to the Assisted Reproductive Services Policy reflect an increased utilization of fertility care within our active duty population. Obstetrics and gynecology (OB/GYN) resident physicians are required to complete training in REI, but many report a lack of formalized education while on their REI rotations, and medical students have endorsed decreased interest in the subspecialty with a smaller proportion of represented research. We aimed to develop a case-based REI curriculum for resident physicians and medical students that fulfills national, standardized objectives and assess if the curriculum increases confidence in managing REI conditions. Materials and Methods: After receiving exemption from our institution’s IRB (protocol number DBS.2023.598, reference 964364), we developed a curriculum using a needs assessment completed by OB/GYN residents in March 2023 who had previously rotated on REI at our institution. A panel of experts wrote the curriculum, which used clinical cases to convey national recommendations and fulfilled learning objectives per the Council on Resident Education. We implemented the curriculum from July 2023 to July 2024 and compared learners’ confidence in diagnosing and managing commonly tested REI conditions using the Wilcoxon signed-rank test. We compared needs assessment responses to post-curriculum responses using the Mann-Whitney U test. Results: Fourteen prior learners completed the needs assessment (response rate 73.6%), all 15 new learners completed the pre-curriculum survey, and 13 of the 15 completed the post-curriculum survey (response rate 86.7%). The curriculum improved the reliability of weekly structured didactics (28.5%-100%) and increased interest in REI grew (28.5%-53.8%). Following curriculum implementation, participants who felt “fairly confident” diagnosing and treating every tested REI condition increased, including amenorrhea (13.3%-84.6%, P < .01), androgen excess (0.0%-69.2%, P < .01), recurrent pregnancy loss (6.67%-76.9%, P < .01), infertility (13.3%-69.2%, P < .01), premenstrual dysphoric disorder (20.0%-53.8%, P = .03), primary ovarian insufficiency (6.67%-53.8%, P < .01), and Mullerian anomalies (6.67%-23.1%, P = .01). Conclusions: A case-based curriculum improved learners’ confidence in diagnosing and managing REI conditions. This curriculum fulfills national learning objectives and can be implemented at medical programs without an REI division. Meeting the rising demand for REIs starts with robust education.

17 April 2024 in Fertility and Sterility
Verified
Journal Article
Closed access
TSTrimble Spitzer
Trimble Spitzer
MDMichael P. Diamond
Michael P. Diamond
RWRobert Wild
Robert Wild
RLRichard Legro
Richard Legro
HZHeping Zhang
Heping Zhang
NSNanette Santoro
Nanette Santoro

19 October 2022 in Military Medicine
Verified
Journal Article
Closed access
PDF file
JKJi Won Kim
Ji Won Kim
BGBenjamin E Grounds
Benjamin E Grounds
KBKelsey C Van Bokkem
Kelsey C Van Bokkem
SRSorana Raiciulescu
Sorana Raiciulescu
TSTrimble L Spitzer
Trimble L Spitzer
Introduction: Twelve percent of reproductive aged females in the United States have utilized fertility services, and it is estimated that 25% of infertility patients have ovulatory dysfunction. Clomiphene and letrozole are currently first-line treatment options for ovulatory dysfunction. These are both disqualifying medications in the U.S. Navy and Air Force for duties that involve flying. These medication restrictions could reduce the likelihood of female aviators seeking infertility treatment. This pilot study seeks to evaluate the severity of common side effects in order to provide recommendations to the current aeromedical guidelines. Materials and Methods: An anonymous survey was provided to all active duty and dependent patients who presented to the infertility clinic at a single military medical center for a mid-cycle scan from February 2021 to February 2022. The survey included demographic, treatment cycle, medication type, medication dose, and the presence and severity of common adverse reactions. The provider additionally recorded the number of dominant follicles that were noted at the time of ultrasound. The Kruskal–Wallis test was used to analyze the severity of adverse effects, and chi-square analysis was used to compare the difference in symptoms from previous cycles. Results: A total of 569 surveys were collected. Of the participants, 45.4% were military members and 3.5% worked in the field of aviation. Letrozole was prescribed to 88.7% of the patients. Less than 3% reported severe or debilitating side effects. There was no difference in presence or severity when comparing the cycle number. Conclusions: The majority of side effects for oral ovulation induction medications were described as slight or mild. Therefore, this study provides evidence-based data of severity side effects that could be used to guide the waiver process and improve readiness for female aviators in the military.